Corcept Therapeutics (CORT) PT Raised to $45 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $26.10 +0.42%
Rating Summary:
9 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 5 | New: 0
Rating Summary:
9 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 5 | New: 0
Join SI Premium – FREE
Ladenburg Thalmann analyst Matt Kaplan raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $45.00 (from $35.00) while maintaining a Buy rating.
You May Also Be Interested In
- GoerTek Inc. (002241:CH) PT Lowered to RMB17.80 at Credit Suisse
- Bharat Electronics Ltd (BHE:IN) PT Raised to INR120 at BofA Securities
- SM Prime Holdings, Inc (SMPH:PM) (SPHXF) PT Lowered to PHP41 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
